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Background: Air pollution is becoming a threatening issue for human health. Many
epidemiological studies relate air pollution index to adverse effects in terms of disease
incidence and/or disease exacerbation. In our previous studies, we found air pollutants
can induce the release of pro-inflammatory cytokines from human peripheral blood cells.
To better understand, the effects of air pollution in the lung, we took advantage of an
animal model.
Experimental Approach: Mice were intratracheally and daily exposed to urban
collected particulate matter (PM, PM10, and PM1) and to the sub-micrometric
carbonaceous component, Soot.
Results: We found that PM10, PM1, and Soot promoted lung inflammation
associated to higher bronchial responsiveness and lower dilation together with an
immunosuppressive lung environment, characterized by tolerogenic dendritic cells (DCs),
macrophages and myeloid -derived suppressor cells (MDSCs), the latter two Arginase I
positive. In support, higher recruitment of Treg associated to higher levels of IL-10 were
detected in the lung of PM10, PM1, and Soot treated mice. This effect was not abolished
by the administration of a caspase-1 inhibitor, Ac-Y-VAD, implying that the canonical
inflammasome complex was not associated to PMx-induced lung immunosuppression
in mice.
Conclusion: Our study proves that PM exposure leads to an immunosuppressive lung
environment in a caspase-1-independent manner, paving the way to understand the
molecular and cellular mechanism/s underlying the establishment of some respiratory
disorders according to the exposure to air pollution.
Keywords: combustion-generated ultrafine particles (UFPs), soot, lung inflammation, airway responsiveness,
immunesuppression
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INTRODUCTION
In the recent decades, air pollution is becoming a growing
cause for concern of human health in that a strong correlation
has been demonstrated between air pollution and a wide
range of adverse effects/disease incidence/disease exacerbation
(WHO 2019, https://www.who.int/airpollution/ambient/health-
impacts/en).
Air pollutants are composed of particulate matter (PM), ozone
(O3), nitrogen dioxide (NO2), nitrogen oxides (NOx), sulfur
dioxide (SO2), and Volatile and Semivolatile Organic Carbon
(VOC and SOC, respectively) (https://www.eea.europa.eu/
publications/air-quality-in-europe-2018). PM directly emitted
from anthropogenic activities (e.g., soot from combustion
sources) or by natural factors (e.g., sea salt and soil from
wind-driven suspension) is defined primary PM. Secondary
PM is instead formed in the atmosphere through oxidation
processes involving precursor pollutants (NOx, VOS and SOC,
SOx) activated by solar radiation. PM can be characterized
in terms of mass concentration of particles with smaller size
than 2.5µm (PM2.5) or 10µm (PM10), in terms of number
concentration of particles (essentially the ultrafine fraction,
i.e., particles with smaller size than 100 nm), or in terms of the
chemical composition (e.g., black carbon, organic compounds
and heavy metals) (1). PM10 may be an appropriate indicator
when considering the impact of resuspension of road dust, while
black carbon is a more sensitive indicator of exhaust emissions
from road traffic (2, 3). Epidemiological and toxicological
evidence show that PM2.5 and PM10 comprise fractions with
varying types and degrees of health effects (http://www.euro.
who.int/__data/assets/pdf_file/0020/182432/e96762-final.pdf).
In particular, in Europe premature deaths are 500.000, among
which 428.000 are related to PM2.5 exposure (https://www.eea.
europa.eu/publications/air-quality-in-europe-2017). Herein,
these concepts are related to the entire world.
The direct link between air pollution and its impact on human
health is represented by the respiratory tract, that allows ultrafine
particles (UFPs, sub-100 nm particles) to settle down in the lower
tract of the respiratory tree (4). Instead, larger PMs (>2.5µm)
tend to be trapped by the nose and upper airways, easily exhaled
and thus at a lower concentration than the PM with smaller
size or UFPs (5). Hence, it is nowadays well established that
UFPs represent the most threatening particles in that they can
localize into the low tract of the respiratory tree leading to
pulmonary diseases (4). In this regard, we proved that UFPs, also
defined as Soot, representative of those encountered in practical
combustion conditions, including gasoline and diesel engines,
induce pro-inflammatory pathways in smokers (6) and chornic
pulmonary disease (COPD) patients (7).
In these latter studies, we found that Soot particles
activate human peripheral blood cells, which then release
pro-inflammatory cytokines (i.e., IL-1-like cytokines) after the
activation of the multiprotein complex inflammasome. In
Abbreviations:WHO,World Health Organization; PM, particulate matter; UFPs,
ultrafine particles; MDSCs, myeloid-derived suppressor cells; DCs, dendritic cells;
Treg, T regulatory cells.
the present study, instead, we took advantage of an animal
model of PM exposure in order to understand the immune
microenvironment in the lung. In particular, we found that urban
collected PM (i.e., PM10 and PM1) and the sub-micrometric
component, Soot, lead toward lung inflammation characterized
by the recruitment of immunosuppressive cells, such as myeloid-
derived suppressor cells (MDSCs) and M2 macrophages, which
were Arginase I positive, and that were correlated to the presence
of both anti-inflammatory cytokines (i.e., IL-10) and suppressive
Treg, paving the way for some respiratory disorders (i.e., cancer).
MATERIALS AND METHODS
Mice
Female specific pathogen-free C57BL/6 mice (6–8 weeks of
age) (Charles River Laboratories, Lecco, Italy) were fed with
a standard chow diet and housed under specific pathogen-free
conditions at the University of Salerno, Department of Pharmacy.
Female mice were chosen because less aggressive than males,
avoiding any interference with the interpretation of the data.
All animal experiments were performed under protocols that
followed the Italian and European Community Council for
Animal Care (2010/63/EU). This study was carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Committee on the
Ethics of Animal Experiments of the University of Salerno and
Health Ministry with the approval number 985/2017.
Experimental Protocol
Mice were intratracheally (i.t.) instilled with Soot (90 ng/mouse),
PM1 (25 ng/10 µl/mouse), PM10 (30 ng/10 µl/mouse),
administered daily and up to the time of mice sacrifice. To
date, PM10, PM1, and Soot doses were chosen according to
preliminary data during which mice were treated in a dose-
dependent manner. The choice of the working dose was based
on the effect on the lung in terms of inflammation, identified as
positive to PAS staining (please refer below). In another group of
mice, Ac-Y-VAD (Y-Vad, 10 µg/mouse), caspase-1 inhibitor, was
intraperitoneally (i.p.) injected every 3 days, as already reported
(8). Mice were divided into the following groups:
1. Vehicle, mice treated with DMSO 0.1%, which was used as
Vehicle to dissolve Soot, PM1 and PM10, n= 8;
2. Soot, i.t. instilled with Soot, n= 8;
3. Soot+Y-Vad, i.t. instilled with Soot and Y-Vad, n= 8;
4. PM1, i.t. instilled with PM1, n= 8;
5. PM1+Y-Vad, i.t. instilled with PM1 and Y-Vad, n= 8;
6. PM10, i.t. instilled with PM10, n= 8;
7. PM10+Y-Vad, i.t. instilled with PM10 and Y-Vad, n= 8;
8. Sham-PBS treated mice, n= 5.
Mice were sacrificed at day 8, 14, and 28 following the first
injection of Soot, PM1 or PM10. Left lung lobes were embedded
into OCT medium to perform PAS staining to evaluate lung
inflammation. Broncho-alveolar lavage fluid (BAL) was collected
using 0.5ml of PBS containing 0.5mM EDTA to measure pro-
inflammatory and anti-inflammatory cytokine levels.
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TABLE 1 | Particle size and composition of PM1, PM10, and Soot samples.
PM1 PM10 Soot
Particle size <1mm <10mm <200 nm
C % 87.5 77 79.5
H % n.d. n.d. 19.5
O % 11.5 19.6 <1
S % 0.8 0.5 n.d.
K % 0.2 0.25 n.d.
Na % n.d. 0.3 n.d.
Mg % n.d. 0.3 n.d.
Al % n.d. 0.3 n.d.
Ca % n.d. 0.75 n.d.
Fe % n.d. 0.25 n.d.
Si % n.d. 0.75 n.d.
n.d., not detected.
Preparation of Particulate Matter
Soot samples were collected from a laboratory flame, which was
run in fuel-rich conditions feeding an ethylene/air mixture with
an equivalence ratio 8 = 2.0 at atmospheric pressure. PM1 and
PM10 samples were collected by means of an automatic outdoor
station for continuous atmospheric particulate sampling (Tecora
Skypost PM HV). The outdoor station was operated in a crowed
area characterized by high automotive traffic during 2018 fall
season and allowed to collect daily samples of particulate matter
on filters. Particulate matter was later suspended in DMSO,
following a sonication-assisted solvent extraction.Table 1 reports
a summary of the elemental composition and size range of the
investigated samples.
Particle morphology and chemical composition were
determined by Scanning Electron Microscopy analysis
performed by a Hitachi TM3000 SEM, coupled with a built-in
energy dispersive Xray detector SwiftED3000.
PAS Staining
Left lung lobes were fixed in OCT medium (Pella Inc.,
Milan, and Italy) and 7µm cryosections were cut. The degree
of inflammation was scored by blinded observers by using
Periodic acid/Alcian blue/Schiff staining (PAS). PAS Staining
(Sigma Aldrich, Milan Italy) was performed according to the
manufacturer’s instructions to detect glycoprotein (9). PAS+
cryosections were graded with scores 0 to 4 to describe low to
severe lung inflammation as follows: 0: <5%; 1: 5 to 25%; 2:
25–50%; 3: 50–75%; 4:<75% positive staining/total lung area.
Airway Responsiveness Measurements
Bronchial rings of 1–2mm length were cut and placed in organ
baths mounted to isometric force transducers (Type 7006, Ugo
Basile, Comerio, Italy) and connected to a Powerlab 800 (AD
Instruments, Ugo Basile, Comerio, Italy). Rings were initially
stretched until a resting tension of 0.5 g was reached and allowed
to equilibrate for at least 30min. In each experiment bronchial
rings were challenged with carbacole in a concentration-
dependent manner (1 pM−10µM) in order to evaluate broncho-
contraction. On the other hand, a cumulative concentration-
response curve to salbutamol (10 pM−30µM) on a stable
tone of carbacole (1µM) was performed in order to evaluate
broncho-dilation.
Flow Cytometry Analysis
Lungs were isolated and digested with 1 U/mL of collagenase
(Sigma Aldrich, Rome, Italy). Cell suspensions were passed
through 70µm cell strainers, and red blood cells were lysed. To
investigate the immune cells infiltrated into the lung of mice, lung
cell suspensions were labeled with specific antibodies (CD11c,
CD11b, Gr-1, F4/80, MHC II, CD80, Arginase I, CD3, CD4,
CD25, and FoxP3).
Cytokine Measurements
IL-1α, IL-1β, IL-33, IL-13, TNFα, IFN-g, and IL-10 were
measured in BAL or lung homogenates as specified in the text,
using commercially available ELISA kits (eBioscience, CA, USA).
In the first case cytokine levels were expressed as pg/ml, whereas
in lung homogenates as pg/mg protein. IL-1α, IL-1β, IL-33,
IL-13, and TNFα cytokines were chosen to evaluate the pro-
inflammatory milieu; whereas IFN-g and IL-10 were chosen to
define the adaptive immune environment.
Statistical Analysis
Data are reported as median ± interquartile range and
represented as box and whiskers. Statistical differences were
assessed with TWO-WAY, ONE-WAY Analysis of variance
(ANOVA) followed by multiple comparison post-tests as
appropriate. Mann–Whitney U-test was performed where
appropriate. p< 0.05 were considered significant.
RESULTS
The Exposure of Mice to Particulate Matter
(PM) Induces Lung Inflammation
It is well-known that PM can be differentiated according
to the size (10). To this end, we collected different PMx,
herein identified as PM10, particles with size smaller than
10µm, as PM1 particles with size smaller than 1µm and
Soot, which represents the carbonaceous component of PM1
and PM10 (Table 1) (11). In order to evaluate the effect of
these three fractions on the lung, mice were i.t. treated every
day. The i.t. instillation of PM10 induced lung inflammation
at 8 and 14 days post-treatment (Figures 1A,B, blue line) as
determined by PAS staining (Figures 1A,B, blue line); whereas,
at 28 days PAS staining did not highlight lung inflammation
following PM10 treatment (Figures 1A,B, blue line) in that
this group of mice had similar lung behavior as the Vehicle
group (DMSO, 0.1%) (Figures 1A,B, black line). Similarly, the
treatment with PM1 induced lung inflammation as higher PAS+
staining at 14 and 28 days (Figures 1A,C, green line), implying
a delayed lung inflammation compared to PM10. Because
both PM1 and PM10 comprise a carbonaceous component,
herein defined as Soot, to evaluate whether anthropogenic
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fraction of PM, that related to automotive traffic, could be
responsible for lung inflammation, mice were treated with
Soot 90 ng/mouse. A marked hyperplasia around bronchi
(Figure 1A) was associated with higher mucus production
at 8 and 28 days, but not at 14 days, post-Soot treatment
(Figure 1D, red line).
To prove bronchial dysfunction after PMx treatment, we
measured airway responsiveness to carbacole and salbutamol. In
the first case, we observed an alteration of the bronchial tone
following a cumulative administration of carbacole in PM10
(Figure 2A) and PM1 (Figure 2C) group of mice compared
to the Vehicle group (Figures 2A,C, black line). In particular,
PM10- (Figure 2A, blue line) and PM1-treated (Figure 2C, green
line) mice showed bronchial responsiveness starting from 0.1µM
of carbacole compared to the Vehicle group (Figures 2A,C,
black line). In contrast, mice treated with Soot did not show
any alteration of the bronchial tone compared to the Vehicle
(Figure 2E). Interestingly, bronchi from PM10- (Figure 2B)
and PM1-treated (Figure 2D) mice did not have an altered
broncodilation under a concentration-dependent challenge of
salbutamol; instead, bronchi from Soot-treated mice showed
a robust reduction of dilation under salbutamol challenge
compared to the Vehicle group (Figure 2F).
Taken together, these data suggest that PMx induce lung
inflammation in mice, although in a different mode in that
they all induce mucus hypersecretion (PAS + staining) but the
smallest component, Soot (20–40 nm) can damage the epithelium
altering the bronchial physiological dilation.
The Exposure of Mice to Particulate Matter
(PM) Induces Lung Immunosuppression
Based on our previous published data, the administration of
PMx can alter immune cell phenotype (6, 7). Therefore, we
evaluated immune cell infiltration in the lung of the five
groups of mice. The administration of PM10 significantly
increased the recruitment of dendritic cells (DCs, identified as
CD11chigh CD11bint F4/80neg) at 8 days (Figure 3A, blue line),
of macrophages (identified as CD11cint CD11bhigh F4/80pos) at
14 days (Figure 3D, blue line), of myeloid-derived suppressor
cells (MDSCs, identified as CD11bhigh Gr-1pos) at 14 and 28 days
(Figure 3G, blue line) and of T regulatory cells (Treg, identified
as CD3+CD25+CD4+FoxP3+) at 14 and 28 days (Figure 3J,
blue line) compared to the Vehicle and Sham group (Figure 3,
black and gray lines). Similarly, the lungs of PM1-treated mice
had significantly higher percentage of recruited macrophages at
14 days (Figure 3E, green line), MDSCs at 14 days (Figure 3H,
green line) and Treg at 14 and 28 days post-treatment (Figure 3K,
green line) compared to the Vehicle group (Figure 3, black
line). No differences were observed with the recruitment of DCs
(Figure 3B, green line) compared to the Vehicle and Sham group
(Figure 3B, black and gray line).
Interestingly, Soot particles had similar behavior to PM10
and PM1 in that they significantly increased the percentage of
DCs (Figure 3C, red line) at 8 days, of macrophages at 14 days
(Figure 3F, red line), of MDSCs at 14 days (Figure 3I, red line)
and of Treg at 28 days (Figure 3L, red line) compared to the
Vehicle and Sham group.
To understand the phenotype of the innate immune cells,
we analyzed the expression of CD80 and MHC II on both
DCs and macrophages. The administration of Soot significantly
increased the levels of CD80 (Figure 4A), but not of MHC
II (Figure 4B) on DCs. To note, Sham mice had very low
levels of CD-80 than the Vehicle group (Figure 4A). Similarly,
macrophages presented higher levels of CD80 (Figure 4C) but
lower levels of MHC II (Figure 4D) compared to the Vehicle
and Sham group. Moreover, macrophages had higher levels of the
immunosuppressive Arginase I in Soot-treatedmice compared to
the Vehicle group (Figure 4E). In the same manner, Arginase I
was significantly higher in lung MDSCs from Soot-treated mice
than Vehicle and Sham group (Figure 4F).
Similar data was observed for PM10- and PM1-treatedmice in
that both macrophages (Vehicle: 27.1 ± 2.6 vs. PM10: 48.5 ± 3.6
or PM1: 42 ± 3.04) and MDSCs (Vehicle: 32.1 ± 1.16 vs. PM10:
59.3 ± 1.43 or PM1: 55.17 ± 1.06) presented higher levels of the
immunosuppressive Arginase I.
To further evaluate the immune microenvironment, pro-
and anti-inflammatory cytokine levels were analyzed. Soot-
treated mice showed a slight increase of IL-1α levels at 14
days (Figure 5A), whereas PM10- (Supplementary Figure 1A)
and PM1- (Supplementary Figure 2A) treated mice showed a
significant increase in this cytokine at later time points, probably
due to the presence of other than carbonaceous components such
as metals and oxides. Soot-, similarly to PM10- (Supplementary
Figure 1B) and PM1- (Supplementary Figure 2B), treated mice
had higher levels of IL-1β levels at earlier time points (Figure 5B).
Similarly, IL-33 levels were higher at earlier time points in Soot-
treated mice (Figure 5C) compared to the Vehicle group. PM10-
(Supplementary Figure 1C) and PM1-treated (Supplementary
Figure 2C) mice had higher levels of IL-33 starting from 8
days up to 28 days of treatment, probably due to the presence
of non-carbonaceous components. Soot-treated (Figure 5D),
differently from PM10- (Supplementary Figure 1D) and PM1-
treated (Supplementary Figure 2D), mice had higher levels of
IL-13, explaining the reduced bronchial dilation observed in
Figure 2F. Instead, no differences were noted for TNFα and
IFNg in the lung of Soot-treated (Figures 5E,F, respectively)
and of PM10- (Supplementary Figures 1E,F) and PM1-treated
(Supplementary Figures 2E,F) mice.
Interestingly, IL-10 levels were significantly higher in Soot-
(Figure 5G), PM10- (Supplementary Figure 1G) and PM1-
treatedmice (Supplementary Figure 2G), further confirming the
immunosuppressive lung microenvironment.
Soot-Induced Immunosuppressive Lung
Microenvironment Was Not Dependent
on Caspase-1
In our previous data (6, 7), we found that the release of IL-1-like
cytokines from Soot-treated human cells was correlated to the
inflammasome complex. Therefore, because caspase-1 is involved
in the inflammasome activation and in IL-1-like cytokine release
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FIGURE 1 | Exposure to PMx induced lung inflammation. Mice were intratracheally daily exposed to PM10 (30 ng/mouse, blue line), PM1 (25 ng/mouse, green line),
and Soot (90 ng/mouse, red line). (A) PAS staining was performed on lung criosection derived from mice sacrificed at 8, 14, and 28 days after PM10, PM1, and soot
exposure. (B–D) Quantitative analysis of PAS staining. Data are represented as mean ± SEM, n = 8. Two-Way ANOVA was performed and followed by Tukey’s
post-hoc test. P < 0.05 was considered significant.
(12, 13), we treated mice with a well-known caspase-1 inhibitor,
Ac-Y-Vad, Y-Vad. The inhibition of caspase-1 significantly
reduced PAS positive staining at 8, but not at 14 days post-
Soot treatment (Figures 6A,B). Bronchial hyperplasia was not
evident in Soot+Y-Vad-treated mice compared to Soot-treated
mice at 8 days (Figure 6A). Nevertheless, this effect was not time-
dependent (Figures 6A,B). Similar data was observed for PM10-
and PM1-treated mice (Supplementary Figures 3A,B).
In support, the recruitment of DCs was decreased at the sole 8
days but not at later time points (Figure 6C) after Soot treatment.
To date, the inhibition of caspase-1 did not alter the recruitment
of macrophages (Figure 6D) and MDSCs (Figure 6E) after
Soot treatment. In the same manner, the levels of IL-1α
(Supplementary Figure 4A), IL-33 (Supplementary Figure 4C)
and IFNg (Supplementary Figure 4D) were not altered in
Soot+Y-Vad- vs. Soot-treated mice. Instead, the levels of IL-1β
(Supplementary Figure 4B) were decreased at the sole 8 days
in Soot+Y-Vad group of mice, implying that the involvement
of caspase-1 in lung inflammation is at early time points and
that it does not play a pivotal role for the induction of late lung
inflammation after PM exposure.
DISCUSSION
In the present study, we found that PM-exposed mice
were susceptible to lung inflammation which was not
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FIGURE 2 | Exposure to PMx altered bronchial responsiveness. Bronchi from mice intratracheally exposed to PM10 (30 ng/mouse, blue line), PM1 (25 ng/mouse,
green line), and Soot (90 ng/mouse, red line) were subjected to carbacol, bronchial contractant, and salbutamol, bronchial dilator. PM10 (A) and PM1 (C) increased
carbacol responsiveness, compared to Soot-treated mice (E). Instead, bronchial dilation was not altered in PM10 (B) and PM1 (D) treated mice, instead Soot-treated
mice showed significantly reduced bronchial dilation to salbutamol (F). Data are represented as mean ± SEM, n = 8. Two-way ANOVA was performed and followed
by Tukey’s post-hoc test. P < 0.05 was considered significant.
characterized by an acute pro-inflammatory, but rather by
an immunosuppressive environment.
PM10, PM1, and Soot were used as examples of particles
mimicking air pollutants in that PM10 represents the entire
class of inhalable atmospheric particles; PM1 represents the
inhalable particulate matter whereas Soot is representative of
the carbonaceous material of anthropogenic origin emitted from
engines. The main difference between Soot and PMx (PM10
or PM1) was the presence of inorganic components such as
metals, sulfur and nitric oxide (Table 1), factors comprising
the ozone-induced secondary aerosol. Besides metals, our data
suggest that the carbonaceous core of PM, Soot, is pivotal for
the induction of lung inflammation. Regarding the term “lung
inflammation” we have to point at the fact that we did not
observe a pro-inflammatory environment, rather, we observed
an immunosuppressive environment. Indeed, the exposure of
mice to PM10, PM1, and Soot increased the recruitment of
innate immune cells such as DCs and macrophages, but these
latter were in their immunosuppressive phenotype. DCs as well
as macrophages presented higher levels of CD80 but lower
levels of MHC II, which translated in a tolerogenic nature of
these cells in that they were not able to induce a cytotoxic
and effective adaptive immunity (14, 15). Indeed, both IFNg
(Supplementary Figure 1) and CD4+ (Vehicle: 21.33 ± 2.4 vs.
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FIGURE 3 | Exposure to PMx altered lung immune microenvironment in a time-dependent manner. Lungs from mice intratracheally exposed to PM10 (30 ng/mouse,
blue line), PM1 (25 ng/mouse, green line), and Soot (90 ng/mouse, red line) were digested with Collagenase and flow cytometry analysis was performed. PM10 (A)
and Soot (C), but not PM1 (B) induced higher recruitment of DCs at early time point. Similarly, PM10 (D), PM1 (E), and Soot (F) induced higher recruitment of
macrophages at 14 days. Higher recruitment of MSDCs was observed after PM10 (G), PM1 (H), and Soot (I) treatment. This effect was associated to higher presence
of Treg after PM10 (J), PM1 (K), and Soot (L) exposure. Data are represented as mean ± SEM, n = 8. Two-Way ANOVA was performed and followed by Tukey’s
post-hoc test. P < 0.05 was considered significant.
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FIGURE 4 | Exposure to Soot altered innate immune cell phenotype recruited to the lung in mice. Soot-treated mice showed higher levels of CD80 (A), but not MHC II
(B) on DCs. Similar effect was observed for macrophages regarding CD80 (C) but not MHC II (D) expression. Macrophages (E) and MSDCs (F) recruited to the lung
of Soot-treated mice showed significantly higher levels of Arginase I. Data are represented as mean ± SEM, n = 8. One-Way ANOVA was performed and followed by
Dunn’s post-hoc test. P < 0.05 was considered significant.
PM10: 29.9 ± 0.6 or PM1: 25.6 ± 1.6) and CD8+ (Vehicle:
11.33 ± 0.8 vs. PM10: 9.8 ± 1.06 or PM1: 15.3 ± 0.96)
T cells were not increased in PM-exposed mice compared
to the Vehicle group. Instead, we observed that macrophages
and MDSCs, which were significantly increased in the lung of
PM-exposed mice, were positive to Arginase I, which is an
enzyme involved in the metabolism of L-Arginine, which is
converted into urea and L-ornitine (16). This metabolic reaction
in innate immune cells is expression of a Th2- or Treg-preferred
immunosuppressive environment which translates in an anti-
inflammatory, tolerogenic activity (16, 17). In this scenario,
PMx and Soot induced recruitment of immunosuppressive DCs,
macrophages and MDSCs was associated to the higher presence
of Treg and higher levels of IL-10 (18), which render the lung
less susceptible to acute inflammatory-driven damages, but pave
the way for higher susceptibility to other respiratory disorders,
such as fibrosis and, even worse, cancer (19). In support, it
is well-known that the immune system plays a pivotal role in
tumor immune escape in that the immune cells are tolerogenic
and therefore incapable of recognizing transformed cells as non-
self (20). In this context, immunosuppression overtakes the
immunostimulatory activity of innate immune cells such as DCs
andmacrophages, which in their tolerant phenotype can facilitate
the immunosuppressive arm of the adaptive immune system
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FIGURE 5 | Exposure to Soot altered cytokine signature into the lung of mice. IL-1a (A) and IL-33 (C) were analyzed in a time-dependent manner in lung
homogenates obtained from Soot-treated mice. IL-1b (B), IL-13 (D), TNFa (E), IFNg (F), and IL-10 (G) were tested in the BAL of Soot-treated mice. Data are
represented as mean ± SEM, n = 8. Two-Way ANOVA was performed and followed by Tukey’s post-hoc test. P < 0.05 was considered significant.
(21). Several epidemiological studies have demonstrated that
there is a direct link between lung cancer and air pollution,
although little is known about the cellular and molecular
underlying mechanism (22). In this study, we found for the
first time, to our knowledge, that the exposure of mice to
air pollutants can create an immunosuppressive environment
that could favor several respiratory disorders. However, we
have to point at a limitation to our study which lacks of the
identification of the molecular sensor for PMx, which still needs
further studies.
Another issue that needs to be pointed at is the airway
responsiveness of mice exposed to the three types of air
pollutants we used. We found that the sole Soot significantly
reduced bronchodilation following salbutamol, a β2 adrenergic
agonist, which is clinically used as an anti-asthmatic as well
as in long-acting β2 adrenergic treatment of COPD patients
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FIGURE 6 | Exposure to Soot induced lung inflammation in a caspase-1-indepdent manner. Mice exposed to Soot showed that the inhibition of caspase-1 was able
to reduce PAS staining at the sole early time point (8 days) (A,B). In support, DCs (C), macrophages (D), and MDSC (E) were still recruited to the lung in
Soot+Y-Vad-treated mice. Data are represented as mean ± SEM, n = 8. Two-Way ANOVA was performed and followed by Tukey’s post-hoc test. P < 0.05 was
considered significant.
(23). It has to be noted that a limitation to our experimental
conditions was the intratracheal exposure that does not entirely
mimic the physiological exposure to air pollution which is
usually suspended in the air as aerosol. However, despite the
limitation about the intratracheal instillation, the reduction of
bronchodilation was observed for the sole Soot most likely due
to the particle size that were instilled compared to PM10 and
PM1, which were of bigger size. In support, in our previous
study we found that peripheral blood cells of COPD patients,
as well as smokers, were more susceptible to Soot exposure in
that they released higher levels of IL-1-like cytokines, which
can participate in an inflammatory context to lung damage
(6). It still remains, though, to elucidate whether Soot-induced
epithelial damage was associated to IL-1-like cytokines, implying
lower dilation of bronchi, typical of asthma, COPD and other
respiratory disorders. Nevertheless, the cross-talk between our
previous data on human primary cells and the actual data on an
animal model is the level of IL-1-like cytokines (i.e., IL-1α, IL-
1β, and IL-33), which are related to the inflammasome complex
activation, most likely associating lung immunosuppression
to pro-fibrotic processes, as observed in other respiratory
diseases (24, 25).
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Therefore, taking advantage of the pre-clinical model, we
used a pharmacological inhibitor of caspase-1, the enzyme
which conveys into the inflammasome complex and that
is able to auto-cleave, promoting IL-1-like cytokine release
(12, 13). Interestingly, we found that the inhibition of
caspase-1 did not alter the recruitment of DCs, macrophages
and MSDCs to the lung of PM-exposed mice. Moreover,
PM-induced immunosuppression was not modified by the
pharmacological inhibition of caspase-1, implying that the
canonical inflammasome complex is not involved. Similarly, in
our previous data, we found that caspase-1 was not responsible
for Soot-induced IL-1 release in COPD-derived PBMCs (6),
confirming that either the non-canonical inflammasome is
involved (26, 27) or that differential molecular mechanism/s can
be induced after PM exposure.
CONCLUSION
This study proves that PM exposure leads to an
immunosuppressive environment in the lung and that this
effect is not associated to the canonical inflammasome, caspase-
1-dependent pathway. These studies can pave the way to
understand the molecular and cellular mechanisms underlying
the establishment of respiratory disorders according to air
pollution exposure.
DATA AVAILABILITY
All datasets generated for this study are included in the
manuscript and/or the Supplementary Files.
ETHICS STATEMENT
All animal experiments were performed under protocols
that followed the Italian and European Community Council for
Animal Care (2010/63/EU). This study was carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Committee on the
Ethics of Animal Experiments of the University of Salerno and
Health Ministry with the approval number 985/2017.
AUTHOR CONTRIBUTIONS
CC, GD, MT, FR, IC, and MS performed experiments. GC, RA,
AD, and AP read and edited the manuscript. RS designed the
experiments, analyzed and interpreted the data.
FUNDING
This study was supported by FARB 2017, FFABR in favor of RS.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fimmu.
2019.01329/full#supplementary-material
Supplementary Figure 1 | Cytokine levels after PM10 exposure. IL-1a (A) and
IL-33 (C) were analyzed in a time-dependent manner in lung homogenates
obtained from PM10-treated mice. IL-1b (B), IL-13 (D), TNFa (E), IFNg (F), and
IL-10 (G) were tested in the BAL of PM10-treated mice. Data are represented as
mean±SEM, n = 8. Two-Way ANOVA was performed and followed by post-hoc
test. P < 0.05 was considered significant.
Supplementary Figure 2 | Cytokine levels after PM1 exposure. IL-1a (A) and
IL-33 (C) were analyzed in a time-dependent manner in lung homogenates
obtained from PM1-treated mice. IL-1b (B), IL-13 (D), TNFa (E), IFNg (F), and
IL-10 (G) were tested in the BAL of PM1-treated mice. Data are represented as
mean ± SEM, n = 8. Two-Way ANOVA was performed and followed by post-hoc
test. P < 0.05 was considered significant.
Supplementary Figure 3 | PAS positive staining analyzed in a time dependent
manner in PM1 (A) and PM 10 (B) treated mice in the presence or not of y-VAD.
Two-Way ANOVA was performed and followed by post-hoc test. P < 0.05 was
considered significant.
Supplementary Figure 4 | Cytokine levels after Soot exposure. IL-1a (A) and
IL-33 (C) were analyzed in a time-dependent manner in lung homogenates
obtained from Soot-treated mice. IL-1b (B) and IFNg (D) were tested in the BAL
of Soot-treated mice in the presence of y-VAD. Data are represented as mean ±
SEM, n = 8. Mann Whitney U-test was performed.
REFERENCES
1. Cassee FR, Héroux ME, Gerlofs-Nijland ME, Kelly FJ. Particulate matter
beyond mass: recent health evidence on the role of fractions, chemical
constituents and sources of emission. Inhal Toxicol. (2013) 25:802–12.
doi: 10.3109/08958378.2013.850127
2. Keuken MP, Jonkers S, Zandveld P, Voogt M, van den Elshout S.
Elemental carbon as an indicator for evaluating the impact of traffic
measures on air quality and health. Atmos Environ. (2012) 61:1–8.
doi: 10.1016/j.atmosenv.2012.07.009
3. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al.
A comparative risk assessment of burden of disease and injury attributable
to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a
systematic analysis for the Global Burden of Disease Study 2010. Lancet.
(2012) 380:2224–60. doi: 10.1016/S0140-6736(12)61766-8
4. Terzano C, Di Stefano F, Conti V, Graziani E, Petroianni A. Air pollution
ultrafine particles: toxicity beyond the lung. Eur Rev Med Pharmacol Sci.
(2010) 14:809–21.
5. Kelly FJ, Fussell JC. Size source and chemical composition as
determinants of toxicity attributable to ambient particulate matter.
Atmos Environ. (2012) 60:504–26. doi: 10.1016/j.atmosenv.2012.
06.039
6. De Falco G, Terlizzi M, Sirignano M, Commodo M, D’Anna A, Aquino RP,
et al. Human peripheral blood mononuclear cells (PBMCs) from smokers
release higher levels of IL-1-like cytokines after exposure to combustion-
generated ultrafine particles. Sci Rep. (2017) 7:43016. doi: 10.1038/srep
43016
7. De Falco G, Colarusso C, Terlizzi M, Popolo A, Pecoraro M, Commodo
M, et al. Chronic obstructive pulmonary disease-derived circulating cells
release IL-18 and IL-33 under ultrafine particulate matter exposure
in a caspase-1/8-independent manner. Front Immunol. (2017) 8:1415.
doi: 10.3389/fimmu.2017.01415
8. Zhang F, Wang L, Wang J, Luo P, Wang X, Xiaa Z. The caspase-1 inhibitor
AC-YVAD-CMK attenuates acute gastric injury in mice: involvement
of silencing NLRP3 inflammasome activities. Sci Rep. (2016) 6:24166.
doi: 10.1038/srep24166
Frontiers in Immunology | www.frontiersin.org 11 June 2019 | Volume 10 | Article 1329
Colarusso et al. Caspase-1 Is Not Involved in PM-Induced Immunesuppression
9. Sorrentino R, Bertolino A, Terlizzi M, Iacono VM, Maiolino P, Cirino
G, et al. B cell depletion increases sphingosine-1-phosphate-dependent
airway inflammation in mice. Am J Respir Cell Mol Biol. (2015) 52:571–83.
doi: 10.1165/rcmb.2014-0207OC
10. Xia T, Zhu Y, Mu L, Zhang ZF, Liu S. Pulmonary diseases induced by ambient
ultrafine and engineered nanoparticles in twenty-first century. Natl Sci Rev.
(2016) 3:416–29. doi: 10.1093/nsr/nww064
11. Lim S, Lee M, Lee G, Kim S, Yoon D, Kang K. Ionic and carbonaceous
compositions of PM10, PM2.5 and PM1.0 at Gosan ABC Superstation
and their ratios as source signature. Chem Phys. (2012) 12:2007–24.
doi: 10.5194/acp-12-2007-2012
12. Terlizzi M, Casolaro V, Pinto A, Sorrentino R. Inflammasome:
cancer’s friend or foe? Pharmacol Ther. (2014) 143:24–33.
doi: 10.1016/j.pharmthera.2014.02.002
13. Colarusso C, Terlizzi M, Molino A, Pinto A, Sorrentino R. Role of
the inflammasome in chronic obstructive pulmonary disease (COPD).
Oncotarget. (2017) 8:81813–24. doi: 10.18632/oncotarget.17850
14. Wilson NS, El-Sukkari D, Villadangos JA. Dendritic cells constitutively
present self antigens in their immature state in vivo and regulate
antigen presentation by controlling the rates of MHC class II synthesis
and endocytosis. Blood. (2004) 103:2187–95. doi: 10.1182/blood-2003-
08-2729
15. Manicassamy S, Pulendran B. Dendritic cell control of tolerogenic responses.
Immunol Rev. (2011) 241:206–27. doi: 10.1111/j.1600-065X.2011.01015.x
16. Munder M. Arginase: an emerging key player in the
mammalian immune system. Br J Pharmacol. (2009) 158:638–51.
doi: 10.1111/j.1476-5381.2009.00291.x
17. Rodriguez PC, Ochoa AC, Al-Khami AA. Arginine metabolism in myeloid
cells shapes innate and adaptive immunity. Front Immunol. (2017) 8:93.
doi: 10.3389/fimmu.2017.00093
18. Mittal SK, Cho KJ, Ishido S, Roche PA. Interleukin 10 (IL-10)-mediated
Immunosuppression: March-i induction regulates antigen presentation by
macrophages but not dendritic cells. J Biol Chem. (2015) 290:27158–67.
doi: 10.1074/jbc.M115.682708
19. Mocellin S, Marincola FM, Young HA. Interleukin-10 and the immune
response against cancer: a counterpoint. J Leukoc Biol. (2005) 78:1043–51.
doi: 10.1189/jlb.0705358
20. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance:
immunoselection and immunosubversion. Nat Rev Immunol. (2006) 6:715–
27. doi: 10.1038/nri1936
21. Sorrentino R, Terlizzi M, Di Crescenzo VG, Popolo A, Pecoraro M, Perillo
G, et al. Human lung cancer-derived immunosuppressive plasmacytoid
dendritic cells release IL-1α in an AIM2 inflammasome-dependent
manner. Am J Pathol. (2015) 185:3115–24. doi: 10.1016/j.ajpath.2015.
07.009
22. Eckel SP, Cockburn M, Shu YH, Deng H, Lurmann FW, Liu L, et
al. Air pollution affects lung cancer survival. Thorax. (2016) 71:891–8.
doi: 10.1136/thoraxjnl-2015-207927
23. La Piana GE, Corda L, Bertella E, Montemurro LT, Pini L, Tantucci C.
Dose-response curve to salbutamol during acute and chronic treatment with
formoterol in COPD. Int J Chron Obstruct Pulmon Dis. (2011) 6:399–405.
doi: 10.2147/COPD.S22179
24. Terlizzi M, Molino A, Colarusso C, Donovan C, Imitazione P, Somma P,
et al. Activation of the absent in Melanoma 2 inflammasome in peripheral
blood mononuclear cells from idiopathic pulmonary fibrosis patients leads
to the release of pro-fibrotic mediators. Front Immunol. (2018) 9:670.
doi: 10.3389/fimmu.2018.00670
25. Colarusso C, Terlizzi M, Molino A, Imitazione P, Somma P, Saccomanno
A, et al. AIM2 inflammasome activation leads to IL-1α and TGF-β
release from exacerbated chronic obstructive pulmonary disease-derived
peripheral blood mononuclear cells. Front Pharmacol. (2019) 10:257.
doi: 10.3389/fphar.2019.00257
26. Terlizzi M, Di Crescenzo VG, Perillo G, Galderisi A, Pinto A, Sorrentino R.
Pharmacological inhibition of caspase-8 limits lung tumour outgrowth. Br J
Pharmacol. (2015) 172:3917–28. doi: 10.1111/bph.13176
27. Terlizzi M, Colarusso C, Popolo A, Pinto A, Sorrentino R. IL-1α and IL-
1β-producing macrophages populate lung tumor lesions in mice. Oncotarget.
(2016) 7:58181–92. doi: 10.18632/oncotarget.11276
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Colarusso, De Falco, Terlizzi, Roviezzo, Cerqua, Sirignano, Cirino,
Aquino, Pinto, D’Anna and Sorrentino. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) and the copyright owner(s) are credited and that the original publication
in this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Immunology | www.frontiersin.org 12 June 2019 | Volume 10 | Article 1329
